These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21029363)

  • 41. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of activated protein C hampers bacterial dissemination during pneumococcal pneumonia.
    de Boer JD; Kager LM; Roelofs JJ; Meijers JC; de Boer OJ; Weiler H; Isermann B; van 't Veer C; van der Poll T
    BMC Infect Dis; 2014 Nov; 14():559. PubMed ID: 25366058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Mohler J; Bédos JP
    Antimicrob Agents Chemother; 2004 Jan; 48(1):80-5. PubMed ID: 14693522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung dendritic cells facilitate extrapulmonary bacterial dissemination during pneumococcal pneumonia.
    Rosendahl A; Bergmann S; Hammerschmidt S; Goldmann O; Medina E
    Front Cell Infect Microbiol; 2013; 3():21. PubMed ID: 23802100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
    Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection.
    Yang H; Ko HJ; Yang JY; Kim JJ; Seo SU; Park SG; Choi SS; Seong JK; Kweon MN
    J Infect Dis; 2013 Jan; 207(1):50-60. PubMed ID: 23100560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia.
    Schauer AE; Klassert TE; von Lachner C; Riebold D; Schneeweiß A; Stock M; Müller MM; Hammerschmidt S; Bufler P; Seifert U; Dietert K; Dinarello CA; Nold MF; Gruber AD; Nold-Petry CA; Slevogt H
    J Innate Immun; 2017; 9(4):403-418. PubMed ID: 28601872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of CD44 in the acute and resolution phase of the host response during pneumococcal pneumonia.
    van der Windt GJ; Hoogendijk AJ; de Vos AF; Kerver ME; Florquin S; van der Poll T
    Lab Invest; 2011 Apr; 91(4):588-97. PubMed ID: 21242959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological effects of corticosteroids on pneumococcal pneumonia in Mice-translational significance.
    Taenaka H; Wick KD; Sarma A; Matsumoto S; Ghale R; Fang X; Maishan M; Gotts JE; Langelier CR; Calfee CS; Matthay MA
    Crit Care; 2024 May; 28(1):185. PubMed ID: 38807178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia.
    Müller-Redetzky HC; Wienhold SM; Berg J; Hocke AC; Hippenstiel S; Hellwig K; Gutbier B; Opitz B; Neudecker J; Rückert J; Gruber AD; Kershaw O; Mayer K; Suttorp N; Witzenrath M
    J Antimicrob Chemother; 2015 Mar; 70(3):830-40. PubMed ID: 25406299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection.
    José RJ; Williams AE; Mercer PF; Sulikowski MG; Brown JS; Chambers RC
    J Immunol; 2015 Jun; 194(12):6024-34. PubMed ID: 25948816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses.
    McConnell KW; McDunn JE; Clark AT; Dunne WM; Dixon DJ; Turnbull IR; Dipasco PJ; Osberghaus WF; Sherman B; Martin JR; Walter MJ; Cobb JP; Buchman TG; Hotchkiss RS; Coopersmith CM
    Crit Care Med; 2010 Jan; 38(1):223-41. PubMed ID: 19770740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
    van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
    J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.
    Mohler J; Azoulay-Dupuis E; Amory-Rivier C; Mazoit JX; Bédos JP; Rieux V; Moine P
    Intensive Care Med; 2003 May; 29(5):808-16. PubMed ID: 12665994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.
    Steinwede K; Henken S; Bohling J; Maus R; Ueberberg B; Brumshagen C; Brincks EL; Griffith TS; Welte T; Maus UA
    J Exp Med; 2012 Oct; 209(11):1937-52. PubMed ID: 23071253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models.
    Abdelraouf K; Nicolau DP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections.
    Kasetty G; Smeds E; Holmberg E; Wrange L; Adikesavan S; Papareddy P
    BMC Microbiol; 2016 Jun; 16(1):129. PubMed ID: 27349742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.